ReviewFrontiers in microbiology2026
Applications of single-cell RNA sequencing in fungal infections.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal infection elicits markedly different cellular responses depending on the pathogen, tissue involved, host immune status, and stage of disease. Bulk measurements capture broad changes but can obscure the cell populations associated with fungal control, persistence, or tissue injury. Single-cell RNA sequencing (scRNA-seq) offers a way to resolve this heterogeneity, although fungal infection studies remain uneven in both technical feasibility and disease coverage. We review evidence from cutaneous, mucosal, pulmonary, central nervous system, and systemic infections, with attention to tissue context, experimental design, and the strength of supporting validation. Across these studies, myeloid, lymphoid, epithelial, and stromal compartments show substantial remodeling, yet similarly named cell states do not necessarily have equivalent functions in different tissues or infections. Direct fungal single-cell studies are fewer, but they reveal variation in developmental stage, morphogenesis, stress responses, and responses to antifungal exposure. Most evidence still centers on
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.